Literature DB >> 31687065

Risk Factors for Symptomatic Atrial Fibrillation-Analysis of an Outpatient Database.

Annabelle Santos Volgman1, Patrick Dunn2, Allison Sundberg2, Scott Conard3, Pavitra Chakravarty3, Zin Htway4, Albert Waldo5, Christine Albert6, Mintu P Turakhia7, Gerald V Naccarelli8.   

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in practice and is the leading cause of debilitating strokes with significant economic burden. It is currently not known whether asymptomatic undiagnosed AF should be treated if detected by various screening methods. Currently, United States guidelines have no recommendations for identifying patients with asymptomatic undiagnosed AF due to lack of evidence. The American Heart Association Center for Health Technology & Innovation undertook a plan to identify tools in 3 phases that may be useful in improving outcomes in patients with undiagnosed AF. In phase I we sought to identify AF risk factors that can be used to develop a risk score to identify high-risk patients using a large commercial insurance dataset. The principal findings of this study show that individuals at high risk for AF are those with advanced age, the presence of heart failure, coronary artery disease, hypertension, metabolic disorders, and hyperlipidemia. Our analysis also found that chronic respiratory failure was a significant risk factor for those over 65 years of age and chronic kidney disease for those less than 65 years of age.

Entities:  

Keywords:  Atrial fibrillation; Left atrial appendage; Stroke

Year:  2019        PMID: 31687065      PMCID: PMC6811334          DOI: 10.4022/jafib.2141

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  13 in total

1.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

2.  Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study.

Authors:  James A Reiffel; Atul Verma; Peter R Kowey; Jonathan L Halperin; Bernard J Gersh; Rolf Wachter; Erika Pouliot; Paul D Ziegler
Journal:  JAMA Cardiol       Date:  2017-10-01       Impact factor: 14.676

Review 3.  Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Salim S Virani; Clifton W Callaway; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Stephanie E Chiuve; Mary Cushman; Francesca N Delling; Rajat Deo; Sarah D de Ferranti; Jane F Ferguson; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Pamela L Lutsey; Jason S Mackey; David B Matchar; Kunihiro Matsushita; Michael E Mussolino; Khurram Nasir; Martin O'Flaherty; Latha P Palaniappan; Ambarish Pandey; Dilip K Pandey; Mathew J Reeves; Matthew D Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Uchechukwu K A Sampson; Gary M Satou; Svati H Shah; Nicole L Spartano; David L Tirschwell; Connie W Tsao; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2018-01-31       Impact factor: 29.690

Review 4.  Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.

Authors:  Ben Freedman; John Camm; Hugh Calkins; Jeffrey S Healey; Mårten Rosenqvist; Jiguang Wang; Christine M Albert; Craig S Anderson; Sotiris Antoniou; Emelia J Benjamin; Giuseppe Boriani; Johannes Brachmann; Axel Brandes; Tze-Fan Chao; David Conen; Johan Engdahl; Laurent Fauchier; David A Fitzmaurice; Leif Friberg; Bernard J Gersh; David J Gladstone; Taya V Glotzer; Kylie Gwynne; Graeme J Hankey; Joseph Harbison; Graham S Hillis; Mellanie T Hills; Hooman Kamel; Paulus Kirchhof; Peter R Kowey; Derk Krieger; Vivian W Y Lee; Lars-Åke Levin; Gregory Y H Lip; Trudie Lobban; Nicole Lowres; Georges H Mairesse; Carlos Martinez; Lis Neubeck; Jessica Orchard; Jonathan P Piccini; Katrina Poppe; Tatjana S Potpara; Helmut Puererfellner; Michiel Rienstra; Roopinder K Sandhu; Renate B Schnabel; Chung-Wah Siu; Steven Steinhubl; Jesper H Svendsen; Emma Svennberg; Sakis Themistoclakis; Robert G Tieleman; Mintu P Turakhia; Arnljot Tveit; Steven B Uittenbogaart; Isabelle C Van Gelder; Atul Verma; Rolf Wachter; Bryan P Yan
Journal:  Circulation       Date:  2017-05-09       Impact factor: 29.690

5.  Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the United States.

Authors:  Mintu P Turakhia; Jason Shafrin; Katalin Bognar; Dana P Goldman; Philip M Mendys; Younos Abdulsattar; Daniel Wiederkehr; Jeffrey Trocio
Journal:  Am J Cardiol       Date:  2015-06-04       Impact factor: 2.778

6.  Pathophysiological determinants of worse stroke outcome in atrial fibrillation.

Authors:  Hans T H Tu; Bruce C V Campbell; Soren Christensen; Marnie Collins; Deidre A De Silva; Kenneth S Butcher; Mark W Parsons; Patricia M Desmond; P Alan Barber; Christopher R Levi; Christopher F Bladin; Geoffrey A Donnan; Stephen M Davis
Journal:  Cerebrovasc Dis       Date:  2010-08-05       Impact factor: 2.762

7.  Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke.

Authors:  Arnaud Bisson; Nicolas Clementy; Alexandre Bodin; Denis Angoulvant; Dominique Babuty; Gregory Y H Lip; Laurent Fauchier
Journal:  Stroke       Date:  2017-09-01       Impact factor: 7.914

8.  A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects.

Authors:  Yan-Guang Li; Daniele Pastori; Alessio Farcomeni; Pil-Sung Yang; Eunsun Jang; Boyoung Joung; Yu-Tang Wang; Yu-Tao Guo; Gregory Y H Lip
Journal:  Chest       Date:  2018-10-04       Impact factor: 9.410

9.  Validation of the Framingham Heart Study and CHARGE-AF Risk Scores for Atrial Fibrillation in Hispanics, African-Americans, and Non-Hispanic Whites.

Authors:  Eric Shulman; Faraj Kargoli; Philip Aagaard; Ethan Hoch; Luigi Di Biase; John Fisher; Jay Gross; Soo Kim; Andrew Krumerman; Kevin J Ferrick
Journal:  Am J Cardiol       Date:  2015-10-19       Impact factor: 2.778

10.  A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study.

Authors:  Ingrid E Christophersen; Xiaoyan Yin; Martin G Larson; Steven A Lubitz; Jared W Magnani; David D McManus; Patrick T Ellinor; Emelia J Benjamin
Journal:  Am Heart J       Date:  2016-05-17       Impact factor: 4.749

View more
  3 in total

1.  Development, validation, and proof-of-concept implementation of a two-year risk prediction model for undiagnosed atrial fibrillation using common electronic health data (UNAFIED).

Authors:  Randall W Grout; Siu L Hui; Timothy D Imler; Sarah El-Azab; Jarod Baker; George H Sands; Mohammad Ateya; Francis Pike
Journal:  BMC Med Inform Decis Mak       Date:  2021-04-03       Impact factor: 2.796

2.  Optimizing Healthcare Through Digital Health and Wellness Solutions to Meet the Needs of Patients With Chronic Disease During the COVID-19 Era.

Authors:  Azizi A Seixas; Iredia M Olaye; Stephen P Wall; Pat Dunn
Journal:  Front Public Health       Date:  2021-07-12

3.  Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation.

Authors:  Xunwei Deng; Jingyuan Hou; Qiaoting Deng; Zhixiong Zhong
Journal:  Lipids Health Dis       Date:  2021-09-29       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.